^
Association details:
Biomarker:NF1 deletion
Cancer:Acute Myelogenous Leukemia
Drug:CI-1040 (MEK inhibitor)
Direction:Resistant
Evidence:
Evidence Level:
Resistant: D – Preclinical
New
Source:
Title:

Response and Resistance to MEK Inhibition in Leukaemias Initiated by Hyperactive Ras

Excerpt:
Here we show that MEK inhibitors are ineffective in MPD, but induce objective regression of many Nf1-deficient AMLs...Mice with AML blasts in the peripheral blood were assigned to treatment with either vehicle (n = 11) or CI-1040 (n = 12)...recipients of Mx1-Cre, Nf1flox/flox AMLs invariably died with recurrent leukaemia despite ongoing treatment…
DOI:
10.1038/nature08279